Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
Atrium Therapeutics, Inc.NASDAQ: RNA
Effect of Forex Changes · Q1 FY2026 · quarter ended Mar 2026
Effect of forex changes of -$415K in Q1 FY2026
Q1 FY2026 effect of forex changes was -$415K.
Context
- Effect of forex changes amounted to 0.0% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Effect of Forex Changes history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Effect of Forex Changes | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Effect of Forex Changes vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Effect of Forex Changes figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.